Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Casco Bay Hemp is a private Maine-based hemp and CBD company that formulates, manufactures, and distributes hemp-derived wellness products for direct-to-consumer, wholesale, white-label, and private-label channels. Its commercial portfolio includes CBD tinctures, gummies, capsules, patches, topicals, pet products, and related cannabinoid formulations. The company emphasizes third-party testing, traceability, and compliance, and states that it serves both U.S. and international markets including Brazil and parts of Europe. Casco Bay Hemp appears to operate as a commercial cannabinoid products manufacturer and brand rather than as a traditional drug-development biotech with a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Casco Bay Hemp.